A distinction was initially made between the phenotypes caused by loss- or gain-of-function ferroportin mutations, which were designated as “subtype 4A or 4B hemochromatosis,” or “type A or B ferroportin disease,” respectively. The gene discussed is SLC40A1; the disease is hemochromatosis.